Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Juli Secures $3.8 Million for AI-powered Platform to Help Manage Chronic Conditions
juli, the AI-powered digital health platform empowering patients and their care teams to manage complex […]
Hundreds of Patients to Benefit From Revolutionary Lung Cancer Drug On The NHS
A revolutionary targeted drug for lung cancer will be made available to anyone who is […]
Gyros Protein Technologies Introduces PurePep Sonata+ Peptide Synthesizer
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in […]
Owkin Welcomes Leading Immuno-oncology Professor as Chief Medical Officer and Senior Pharma Exec as SVP Data Science
Owkin appointed Professor Vassili Soumelis as Chief Medical Officer and Eric Durand as SVP Data […]
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics
Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve […]
Seegene Appoints Richard Creager as CEO of U.S. Subsidiary to Bolster U.S. Business
Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today announced the appointment of Richard S. Creager, Ph.D., […]
Rondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors
Rondo Therapeutics, a biopharmaceutical company advancing a next-generation immuno-oncology platform for treating solid tumors, today […]
NICO Corporation New Technology Enables Option for Neurosurgeons to Avoid Pinning Patients' Heads for Brain Surgery
Medical device innovator NICO Corporation is the first and only provider to offer an adapter for electromagnetic […]
Ro Acquires Sperm Analysis and Storage Company Dadi to Offer a Suite of At-Home Fertility Services
Ro, a direct-to-patient healthcare company, today announced the acquisition of Dadi, a fertility company specializing […]
Antengene Announces XPOVIO ® Regulatory Approval in Singapore for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Three Indications
Antengene Corporation Limited (“Antengene” SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more